153 related articles for article (PubMed ID: 37652523)
21. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
22. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
Masunaga S; Ono K; Tsutsui K; Abe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
[TBL] [Abstract][Full Text] [Related]
23. The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma.
Lyhne NM; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Evensen J; Mortensen HR; Overgaard J
Radiother Oncol; 2015 Oct; 117(1):91-8. PubMed ID: 26255764
[TBL] [Abstract][Full Text] [Related]
24. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
[TBL] [Abstract][Full Text] [Related]
25. Poor local control of ulcerative T1 glottic cancer treated with 2.25-Gy per fraction radiotherapy.
Oie Y; Itoh Y; Kawamura M; Takase Y; Murao T; Ishihara S; Nomoto Y; Hirasawa N; Asano A; Yamakawa K; Ito J; Kinoshita F; Naganawa S
Nagoya J Med Sci; 2021 Nov; 83(4):811-825. PubMed ID: 34916724
[TBL] [Abstract][Full Text] [Related]
26. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
27. Patterns of failure for early-stage glottic carcinoma: 10 years' experience in conformal radiotherapy era.
Sert F; Kaya I; Ozturk K; Esassolak M
J Cancer Res Ther; 2019; 15(3):576-581. PubMed ID: 31169223
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.
Chung SY; Kim KH; Keum KC; Koh YW; Kim SH; Choi EC; Lee CG
Cancer Res Treat; 2018 Jan; 50(1):156-163. PubMed ID: 28301924
[TBL] [Abstract][Full Text] [Related]
29. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery.
Spector JG; Sessions DG; Chao KS; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Mar; 21(2):116-23. PubMed ID: 10091979
[TBL] [Abstract][Full Text] [Related]
30. The impact of radiation dose and fractionation on outcomes for limited-stage small-cell lung cancer.
Tomita N; Kodaira T; Hida T; Tachibana H; Nakamura T; Nakahara R; Inokuchi H
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1121-6. PubMed ID: 19665321
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy with or without chemotherapy for patients with T1-T2 glottic carcinoma: retrospective analysis.
Hirasawa N; Itoh Y; Ishihara S; Kubota S; Itoh J; Fujimoto Y; Nakashima T; Naganawa S
Head Neck Oncol; 2010 Jul; 2():20. PubMed ID: 20673360
[TBL] [Abstract][Full Text] [Related]
32. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
33. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer.
Lee SW; Kim YJ; Shin KH; Kim K; Chie EK; Han W; Im SA; Jung SY; Lee KS; Lee ES
Medicine (Baltimore); 2016 May; 95(19):e3320. PubMed ID: 27175630
[TBL] [Abstract][Full Text] [Related]
34. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
Yu E; Shenouda G; Beaudet MP; Black MJ
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
[TBL] [Abstract][Full Text] [Related]
35. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
36. Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.
Sakata K; Oouchi A; Nagakura H; Akiba H; Tamakawa M; Koito K; Hareyama M; Asakura K; Satoh M; Ohtani S
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):81-8. PubMed ID: 10758308
[TBL] [Abstract][Full Text] [Related]
37. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
38. Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma.
Kimura K; Itoh Y; Okada T; Nakahara R; Kawamura M; Kubota S; Itoh J; Hiramatsu M; Fujimoto Y; Shibata T; Naganawa S
Anticancer Res; 2015 Apr; 35(4):2385-90. PubMed ID: 25862904
[TBL] [Abstract][Full Text] [Related]
39. A Randomized Prospective Study of Concurrent Chemo-Radiotherapy vs Accelerated Hyperfractionation in Advanced Cancer of Head and Neck.
Mishra H; Mishra R; Shahi UP; Mandal A
J Clin Diagn Res; 2016 Oct; 10(10):XC15-XC18. PubMed ID: 27891443
[TBL] [Abstract][Full Text] [Related]
40. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]